Tag: MindMedicine - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article MindMed to Participate in the Jefferies London Healthcare Conference

MindMed to Participate in the Jefferies London Healthcare Conference

Post published:November 11, 2022
Post category:Press Release

Read more about the article MindMed to Host Earnings Call to Discuss Third Quarter 2022 Financial Results and Provide Business Update

MindMed to Host Earnings Call to Discuss Third Quarter 2022 Financial Results and Provide Business Update

Post published:November 5, 2022
Post category:Press Release

Read more about the article MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference

MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference

Post published:October 6, 2022
Post category:Press Release

Read more about the article MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMA

MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMA

Post published:October 5, 2022
Post category:Press Release

Read more about the article MindMed Announces Pricing of Public Offering of Common Shares and Warrants

MindMed Announces Pricing of Public Offering of Common Shares and Warrants

Post published:September 28, 2022
Post category:Press Release

Read more about the article MindMed Announces Proposed Public Offering of Common Shares

MindMed Announces Proposed Public Offering of Common Shares

Post published:September 28, 2022
Post category:Press Release

Read more about the article MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances

MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances

Post published:September 21, 2022
Post category:Press Release

Read more about the article MindMed Announces Compliance with Nasdaq Listing Requirements

MindMed Announces Compliance with Nasdaq Listing Requirements

Post published:September 15, 2022
Post category:Press Release

Read more about the article MindMed Announces Positive Results from Collaborators’ Placebo-Controlled Investigator-Initiated Trial Published in Peer-Reviewed Journal

MindMed Announces Positive Results from Collaborators’ Placebo-Controlled Investigator-Initiated Trial Published in Peer-Reviewed Journal

Post published:September 9, 2022
Post category:Press Release

Read more about the article MindMed to Participate in H.C. Wainwright Global Investment Conference

USA – English

USA – English

USA – English

MindMed to Participate in H.C. Wainwright Global Investment Conference USA – English USA – English USA – English

Post published:September 7, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.